Annual Report • Apr 29, 2022
Annual Report
Open in ViewerOpens in native device viewer
ANNUAL REPORT 2021
| CONSOLIDATED BALANCE SHEET | 0 1 |
|---|---|
| CONSOLIDATED INCOME STATEMENT | 02 |
| CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME | 03 |
| TABLE OF CONSOLIDATED CASH FLOWS | 04 |
| CONSOLIDATED STATEMENT OF CHANGES IN EQUITY | 05 |
| AUDITOR'S REPORT | 06 |
| FINANCIAL CALENDAR | 13 |
| ASSETS IN EUR THOUSANDS | Note | 31/12/21 | 31/12/20 |
|---|---|---|---|
| NON-CURRENT ASSETS | 221,325 | 187,709 | |
| Intangible assets | 11 | 19,732 | 4,187 |
| Goodwill | 11 | 98,711 | 96,405 |
| Right-of-use assets | 12 | 5,722 | 8,384 |
| Tangible assets | 12 | 80,011 | 66,257 |
| Holdings consolidated using the equity method | 13 | 2,861 | 2,604 |
| Deferred tax assets | 14 | 1,441 | 4,357 |
| Other assets | 15 | 12,846 | 5,514 |
| CURRENT ASSETS | 196,049 | 203,048 | |
| Inventories | 17 | 50,039 | 46,973 |
| Biological inventories | 17 | 3,322 | 3,508 |
| Trade receivables | 26 | 64,500 | 61,230 |
| Current tax assets | 11,927 | 9,548 | |
| Other financial assets | 18 | 1,322 | 616 |
| Cash and cash equivalents | 19 | 52,949 | 49,477 |
| Other assets | 15 | 11,990 | 9,041 |
| 196,049 | 180,391 | ||
| Assets held for sale | 16 | 0 | 22,657 |
| TOTAL ASSETS | 417,374 | 390,756 | |
| EQUITY AND LIABILITIES IN EUR THOUSANDS | Note | 31/12/21 | 31/12/20 |
| TOTAL EQUITY | 24 | 171,905 | 142,883 |
| Floridienne equity | 131,611 | 117,292 | |
| Non-controlling interests | 40,294 | 25,591 | |
| LIABILITIES | 245,469 | 247,874 | |
| Non-current liabilities | 143,776 | 138,670 | |
| Interest-bearing debts | 20 | 119,808 | 119,221 |
| Lease commitment debts | 20 | 4,156 | 6,370 |
| Subsidies received | 5,235 | 2,574 | |
| Provisions | 21 | 1,375 | 1,319 |
| Staff benefits | 22 | 1,837 | 1,859 |
| Deferred tax liabilities | 14 | 5,166 | 2,888 |
| Other long-term debts | 20 | 6,200 | 4,439 |
| Current liabilities | 101,693 | 109,204 | |
| Interest-bearing debts | 20 | 30,399 | 28,915 |
| Lease commitment debts | 20 | 1,606 | 1,857 |
| Subsidies received | 234 | 199 | |
| Provisions | 21 | 56 | 27 |
| Staff benefits | 22 | 804 | 731 |
| Trade payables | 26 | 38,130 | 30,351 |
| Current tax liabilities | 7,533 | 6,631 | |
| Other liabilities | 23 | 22,931 | 20,911 |
| 101,693 | 89,622 | ||
| Liabilities associated with assets held for sale | 16 | 0 | 19,582 |
| TOTAL LIABILITIES | 417,374 | 390,756 |
The consolidated equity amounted to € 171.9 million as at 31 December 2021, compared with € 142.9 million as at 31 December 2020.
The net financial indebtedness of the Group fell by € 5.5 million in 2021 to € 97.3 million (excluding lease commitment debts (IFRS 16). This fall may be attributed primarily to the positive cash flows generated by the Group's activities during the financial year. The consolidated cash position is sound at € 52.9 million.
| Note | 31/12/21 | 31/12/20 | |
|---|---|---|---|
| OPERATING INCOME | 362,779 | 380,287 | |
| Turnover | 6 | 353,094 | 373,942 |
| Other operating income | 6 | 9,684 | 6,345 |
| OPERATING EXPENSES (-) | -317,035 | -342,238 | |
| Raw materials and consumables | -157,202 | -193,519 | |
| Staff costs | -79,905 | -75,792 | |
| Other operating expenses | 6 | -79,928 | -72,927 |
| EBITDA | 45,744 | 38,049 | |
| Amortisation and impairment | 7 | -15,286 | -18,667 |
| OPERATING RESULT | 30,458 | 19,382 | |
| Result from disposal of non-current assets | 8 | 1,465 | -404 |
| Debt burden | 9 | -4,818 | -3,443 |
| Other financial results | 9 | -247 | -153 |
| Share of the net result of equity-accounted companies | 13 | 53 | 48 |
| RESULT BEFORE TAX | 26,911 | 15,430 | |
| Tax on the result | 10 | -8,318 | -6,987 |
| CONSOLIDATED RESULT FOR THE FINANCIAL YEAR | 18,593 | 8,443 | |
| Attributable to Floridienne shareholders | 13,173 | 4,273 | |
| Attributable to non-controlling interests | 5,420 | 4,170 | |
| Net result attributable to Floridienne per basic share | 25 | 13.45 | 4.36 |
| Net result attributable to Floridienne per diluted share | 25 | 13.45 | 4.36 |
The Floridienne Group turnover in 2021 amounted to € 353.1 million, down 13% compared with € 373.9 million in 2020. This reduction of € 20.8 million may be attributed mainly to the removal of SALM INVEST and GEL MANCHE from the consolidation scope in January 2021 and that of IKA on 30 September 2020 further to their disposal. These removals were nevertheless partially offset by the entry into the consolidation scope of Biological Services in 2021 and that of Beneficial Insectary on 30 November 2020, as well as internal growth.
The EBITDA amounted to € 45.7 million as at 31 December 2021, up € 7.7 million compared with € 38 million as at 31 December 2020 thanks to the dynamism of our Life Science Division (+ € 6.5 million brought in, mainly through acquisitions) and our Chemicals Division (+ € 1.4 million brought in by organic growth and exchange rate effects at Kimflor).
Amortisations and impairments amounted to € 15.3 million, down € 3.4 million compared with the previous year. As at 31 December 2021, these included extraordinary impairments on CHEMCOM (€ 2.5 million, IKA (€ 1.2 million) and SOPRAL (€ 0.4 million).
The operating result rose by € 11.1 million owing to the extraordinary impairments recognised in 2020. It stood at € 30.5 million in 2021, compared with € 19.4 million the year before.
The disposal of SALM INVEST and GEL MANCHE in January 2021 led to recognition of a gain of € 1.5 million. The sale of our vanilla activities (SOPRAL and KAMAPIN) did not result in a significant gain or loss.
The disposal of IKA was concluded on 6 October 2020 and resulted in an accounting loss of € 1.6 million recognised in impairments for € 1.2 million (booked as at 30 June 2020) and in the result on the disposal of non-current assets for € 0.4 million.
The disposal of SALM INVEST and GEL MANCHE in January 2021 led to recognition of a gain of € 1.5 million. The sale of our The sale of our vanilla activities (SOPRAL and KAMAPIN) did not result in a significant gain or loss.
The Group therefore closed its 2021 financial year with an improved consolidated net result of € 18.6 million, up € 10.2 million compared with € 8.4 million in 2020. The Group's share of the net result increased to € 13.2 million, compared with € 4.3 million as at 31 December 2020.
| 31/12/21 | 31/12/20 | |
|---|---|---|
| Consolidated result for the financial year | 18,593 | 8,443 |
| Other comprehensive income | ||
| Items that can be reclassified in the income statement in future financial years | ||
| Changes in the fair value of financial assets through other comprehensive income (FVOCI) | ||
| Gain / loss (net) on cash flow hedges | -1,314 | 547 |
| Conversion rate adjustments linked to consolidated companies | -114 | -6,327 |
| Other changes | ||
| Items that cannot be reclassified in the income statement in future financial years | ||
| Actuarial gains (losses) from defined benefits | 0 | 0 |
| TOTAL COMPREHENSIVE INCOME FOR THE PERIOD AFTER TAXES | 17,165 | 2,663 |
| Attributable to: | ||
| Floridienne shareholders | 12,662 | -336 |
| Non-controlling interests | 4,503 | 2,999 |
The conversion rate adjustments relate mainly the TRY and USD.
| Result for the financial year before taxes 26,911 15,430 Amortisation - impairment 7, 11 16,844 18,885 Impairment on inventories -53 195 Result of companies consolidated using the equity method 13 283 -48 Provisions 21 -1,950 67 Capital gains / losses on the disposal of assets 8 -7,871 643 Taxes for the financial year 10 6,057 -6,618 Financial charges 9 -2,424 4,378 Other 0 868 SELF-FINANCING GROSS MARGIN 37,798 33,801 Changes in current assets / liabilities Inventories 17 -4,754 -2,136 Receivables and other 27 -8,084 995 Amounts payable 27 571 -6,270 CHANGE IN THE WORKING CAPITAL REQUIREMENT -12,266 -7,410 NET CASH FLOW RELATING TO OPERATING ACTIVITIES 25,532 26,390 Investment transactions Acquisitions of intangible assets 11 -1,568 -991 Acquisitions of tangible assets 12 -26,071 -14,543 Acquisitions of financial assets after deduction of cash acquired 13, 15 -10,445 -29,292 Acquisitions of other financial assets 13, 15 -7,991 -9 New loans 15 -302 -471 TOTAL INVESTMENTS -46,377 -45,305 Divestment transactions Disposals of intangible assets 11 0 31 Disposals of tangible assets 12 1,749 241 Disposals of financial assets after deduction of cash disposed of 13, 15 5,966 9,185 Income from holdings 0 99 Repayment of loans 15 58 115 TOTAL DIVESTMENTS 7,774 9,671 CASH FROM INVESTMENTS -38,603 -35,634 Financing transactions Capital increases in non-controlling holdings 20,812 662 Acquisitions and disposals of financial assets -639 -18 New loans and subsidies 20 15,246 56,055 Repayment of financial debts 9 -10,868 -6,018 Change in bank overdraft 24 4,188 -5,746 Financial charges -6,057 -4,378 Dividends paid by the parent company -2,253 0 Changes in own shares 0 0 Dividends paid by subsidiaries to non-controlling holdings -3,434 -2,295 CASH FROM FINANCING ACTIVITIES (+/-) 16,996 38,262 CHANGES IN CASH POSITION 3,924 29,018 Cash in hand at the start of the financial year 49,477 22,091 Net change 3,924 29,018 Conversion rate adjustments -453 -1,472 Other movements 0 0 Cash in hand at the end of the financial year |
Notes | 31/12/21 | 31/12/20 |
|---|---|---|---|
| 52,949 | 49,637 |
| Share capital |
Share premium at issue |
Revaluation reserves |
Own shares |
Conso lidation reserves |
Conver sion rate adjust ments |
Floridienne equity |
Non controlling interests |
Total equity |
|
|---|---|---|---|---|---|---|---|---|---|
| Opening balance as at 01/01/2020 |
4,855 | 30,570 | (270) | (1,868) | 97,109 | (10,668) | 119,728 | 23,646 | 143,374 |
| Result for the financial year | 4,273 | 4,273 | 4,170 | 8,443 | |||||
| Other comprehensive income |
547 | (5,156) | (4,609) | (1,171) | (5,780) | ||||
| Total comprehensive income | - | - | 547 | - | 4,273 | (5,156) | (336) | 2,999 | 2,663 |
| Capital increases | - | - | |||||||
| Capital increases subsidiaries subscribed by third parties |
- | 710 | 710 | ||||||
| Dividends | - | (2,277) | (2,277) | ||||||
| Own shares (bought)/sold | - | - | |||||||
| Re-assessment of debts linked to selling and buying options with non-controlling interests |
(1,456) | (1,456) | (1,456) | ||||||
| Transactions with non controlling interests |
(645) | (645) | 514 | (131) | |||||
| Closing balance as at 31/12/2020 |
4,855 | 30,570 | 277 | (1,868) | 99,281 | (15,824) | 117,291 | 25,592 | 142,883 |
| Opening balance as at 01/01/2021 |
4,855 | 30,570 | 277 | (1,868) | 99,281 | (15,824) | 117,291 | 25,592 | 142,883 |
| Result for the financial year | 13,173 | 13,173 | 5,420 | 18,593 | |||||
| Other comprehensive income |
(1,314) | 802 | (512) | (917) | (1,429) | ||||
| Total comprehensive income | - | - | (1,314) | - | 13,173 | 802 | 12,661 | 4,503 | 17,164 |
| Capital increases | - | - | |||||||
| Capital increases subsidiaries subscribed by third parties |
|||||||||
| Dividends | (2,252) | (2,252) | (3,203) | (5,455) | |||||
| Own shares (bought)/sold | - | - | |||||||
| Re-assessment of debts linked to selling and buying options with non-controlling interests |
(2,548) | (2,548) | (2,548) | ||||||
| Transactions with non controlling interests |
6,458 | 6,458 | 13,402 | 19 860 | |||||
| Closing balance as at 31/12/2021 |
4,855 | 30,570 | (1,037) | (1,868) | 114,112 | (15,022) | 131,610 | 40,294 | 171,904 |
In 2021, the equity situation was impacted mainly by:
• the consolidated result for the period of € 18.6 million
• the dividend paid by the parent company to Floridienne S.A. shareholders (- € 2.3 million) for the 2020 financial year and the dividends paid to non-controlling shareholders in certain consolidated companies for the 2021 financial year (• € 3.2 million)
• the capital increase in SNAM (€ 10 million), BIOBEST (€ 10 million) and other companies in the Group (€ 1 million), totalling € 21 million
• the change in conversion rate adjustments (• € 0.1 million)
As regards the 2021 financial year, the Floridienne Board of Directors will put a proposal to the Floridienne General Meeting to pay a gross dividend of € 2.5 per share.
Statutory Auditor's report 31 December 2021
AUDIT | TAX | CONSULTING
In the context of the statutory audit of the consolidated financial statements of Floridienne SA (the « Company ») and its subsidiaries (together referred to as « the Group »), we hereby present our statutory auditor's report. It includes our report on the audit of the consolidated financial statements as well as the other legal and regulatory requirements. This is an integrated whole and is indivisible.
We have been appointed in the capacity of statutory auditor by the general shareholder's meeting of 1 June 2021, following the proposal formulated by the board of directors issued upon recommendation of the auit committee. Our statutory auditor's mandate expires on the date of the general meeting deliberating on the consolidated financial statements for the year ended 31 December 2023. We have performed the statutory audit of the consolidated financial statements of Floridienne SA for the first time this year.
We have audited the consolidated financial statements of the Group, which comprise the consolidated statement of the financial position as at 31 December 2021, the consolidated income statement and other comprehensive income, the consolidated statement of changes in equity and the consolidated statement of cash flows fo the year then ended and the notes to the consolidated financial statements, including a summary of significant accounting policies and other explanatory information. Those consolidated financial statements show a balance sheet total of € 417.374 (000) and a profit for the year of € 18.593 (000).
In our opinion, the consolidated financial statements give a true and fair view of the Group's net equity and financial position as at 31 December 2021, as well as of its consolidated results and its consolidated cash flows for the year then ended, in accordance with International Financial Reporting Standards (IFRS) as adopted by the European Union and with the legal and regulatory requirements applicable in Belgium.
We conducted our audit in accordance with International Standards on Auditing (ISAs) as applicable in Belgium. Our responsibilities under those standards are further described in the 'Statutory auditor's responsibilities for the audit of the consolidated financial statements' section in this report. We have complied with all the ethical
RSM Belgium is a member of the RSM network and trades as RSM. RSM is the trading name used by the members of the RSM Network. Each member of the RSM network is an independent accounting and consulting firm which practices in his own right. The RSM network is not itself a separate legal entity in any jurisdiction.
RSM Réviseurs d'entreprises - Bedrijfsrevisoren BV-SRL - Registered auditors - – Registered office : Chaussée de Waterloo 1151 - B 1180 Brussels [email protected] - VAT BE 0429.471.656 - RLP Brussels
requirements that are relevant to the audit of consolidated financial statements in Belgium, including those regarding independence.
We have obtained from the board of directors and Company's officials the explanations and information necessary for performing our audit.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Without qualifying our opinion expressed here above, we draw attention to:
Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the financial statements of the current period. These matters were addressed in the context of our audit of the financial statements as a whole, and in forming our opinion thereon. We do not provide a separate opinion on these matters.
| Description of the key audit matter | How our audit addressed the key audit matter |
|---|---|
| 1. Valuation of goodwill |
ef |
| As of December 31, 2021, the net goodwill included in the assets of the Group's balance sheet amounts to €98,711 (000) and represents 23.7% of total assets. Details of goodwill are presented in note 11 to the consolidated financial statements. According to IFRS [IAS 36 – Impairment of Assets], the company must perform an annual impairment test on goodwill. Based on the annual goodwill impairment test, the board of directors concluded that no goodwill impairment was necessary. The main assumptions and sensitivities are presented in note 11 to the consolidated financial statements. We considered that the valuation of goodwill as well as the annual impairment test on these assets constitute a key audit matter due to (1) the importance of these assets in the consolidated financial statements of Floridienne and (2) the required judgments and accounting estimates made by the board of directors in the assessment of potential impairment losses, which are based on assumptions (forecast data and valuation parameters) that could be influenced by current and future economic conditions. |
Our approach to assessing the valuation of goodwill is based on a detailed analysis of the forecasts and the annual impairment test. The work consisted, among other things, of: - an assessment of the mathematical accuracy of the calculations; - reconciliation with the forecast data approved by the management committee; - an analysis of the assumptions used in the analytical process underlying the annual impairment test prepared by the board of directors, including future cash flows, growth rates, discount rates and other relevant assumptions; - a "robustness" test of the assumptions with regard to past experience, in particular the assumptions applied in the models used previously; and - assessment of the adequacy and appropriateness of the information provided by the company in note 11 to the consolidated financial statements in accordance with IAS 36. Our financial valuation specialists were involved in carrying out these procedures. Reference to the notes to the consolidated financial statements – Reference is made to the valuation of goodwill in note 11. |
| 2. Accounting for business combinations |
|
| In 2021, the Group entered into a business combination (IFRS 3 – Business Combination), through the acquisition of the Australian company Biological Services (Life Sciences division) from January 1, 2021 onwards. Following this operation, the Group made a provisional allocation of the purchase consideration leading to the allocation of goodwill totaling €12,000 (000). The final allocation of the purchase considation has not yet been finalized, as the Group has 12 months following the date of the obtaining control (IFRS 3). We considered the business combination with Biological Services to be material to our audit because of the judgments used in determining the date of obtaining control. The Group has also definitively allocated the purchase consideration and relating goodwill as part of the business combination with Beneficial Insectary. This allocation of goodwill to underlying assets and liabilities amounts to a net (asset) value of €12,200 (000) and results in a residual goodwill of €20,600 (000). We considered the purchase price allocation of Beneficial Insectary to be material to our |
With regard to accounting for business combinations, we have, among others: - examined the acquisition agreement; - assessed the appropriateness of the accounting treatment; - assessed the information included in the notes to the consolidated financial statements in this respect (note 32); - carried out specific procedures on the opening balance sheet, in particular on the basis of financial and legal due diligence reports; and - verified the identification and consistency of the assumptions leading to the determination of the value of the assets acquired and the liabilities assumed by the Group (note 11). Our financial valuation specialists were involved in carrying out these procedures. Reference to the notes to the consolidated financial statements – Reference is made to the business |
| audit because of the judgments made in this exercise. | combination in notes 11 and 32. |
The board of directors is responsible for the preparation of consolidated financial statements that give a true and fair view in accordance with the International Financial Reporting Standards (IFRS) as adopted by the European Union, and for such internal control as the board of directors determines is necessary to enable the preparation of consolidated financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the consolidated financial statements, the board of directors is responsible for assessing the Group's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the board of directors either intends to liquidate the Group or to cease operations, or has no realistic alternative but to do so.
Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a statutory auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these consolidated financial statements.
In performing our audit, we comply with the legal, regulatory and normative requirements applicable to the audit of consolidated financial statements in Belgium. A statutory audit does not provide any assurance as to the Group's future viability nor as to the efficiency or effectiveness of the board of directors has conducted or will conduct the business operations of the Group. Our responsibilities in relation to the board of director's use of the going concern accounting principle are described below.
As part of an audit in accordance with ISAs, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:
We also provide the the audit committee with a statement that we have complied with relevant ethical requirements regarding independence, and disclose to them, where appropriate, all relationships and other factors that may reasonably be thought to be a threat to our independence and any safeguards relating thereto.
Among the items reported to the audit committee, we determine which topics were most significant in the audit of the financial statements of the current period and are therefore the key audit matters. We describe these matters in our statutory auditor's report, unless law or regulation precludes public disclosure about the report or in extremely rare circumstances, we determine that the matter should not be communicated in the auditor's report because the adverse consequences of doing so would reasonably be expected to outweigh the public interest benefits of such communication.
The board of directors is responsible for the preparation and the content of the directors' report and of the other non-financial information included in the annual report on the consolidated financial statements.
In the context of our audit mandate and in accordance with the Belgian standard (revised version 2020) which is complementary to the International Standards on Auditing (ISAs) as applicable in Belgium, it is our responsibility to verify, in all material aspects, the directors' report on the consolidated financial statements and the other information included in the annual report, as well as to report on these matters.
In our opinion, after having performed specific procedures in relation to the directors' report, the directors' report is consistent with the consolidated financial statements for the same financial year, and it is prepared in accordance with articles 3:32 of the Code of companies and associations.
In the context of our audit of the consolidated financial statements, we are also responsible for considering, in particular based on the knowledge acquired resulting from the audit, whether the directors' report on the consolidated financial statements and the other information included in the annual report, namely Group Profile, Key Figures of the Group and Corporate Governance Statement contain a material misstatement, i.e. information which is inadequately disclosed or otherwise misleading.
The non-financial information required by article 3:32, § 2 of the Companies and Associations Code is included in the director's report on the consolidated financial statements, section "Statement on non-financial information / Corporate Social Responsibility". For the preparation of this non-financial information, the Group has not based itself on a recognized European or international reference framework and the declaration does not cover all the non-financial topics provided for by article 3 of the law of September 3, 2017.
Based on the procedures performed, there are no other material misstatements we have to report to you. Furthermore, we do not express any form of assurance on the director's report or the other information included in the annual report (including non-financial information).
In accordance with the standard relating to the verification of compliance of financial statements with the Single European Electronic Format (hereinafter "ESEF"), we must verify compliance with the ESEF format with the regulatory technical standards defined by European Delegated Regulation No. 2019/815 of December 17, 2018 (hereinafter "Delegated Regulation"). The administrative body is responsible for drawing up, in accordance with ESEF requirements, consolidated financial statements in the form of an electronic file in ESEF format (hereinafter digital consolidated financial statements) included in the annual financial report. Our responsibility is to obtain sufficient and appropriate evidence to conclude that the format and XBRL markup of the digital consolidated financial statements comply, in all material respects, with the ESEF requirements under the Delegated Regulation. The annual financial report and the digital consolidated financial statements have not yet been delivered to us at the date of this report. If, upon reviewing the digital consolidated financial statements, we conclude that there is a material misstatement, we will be required to report the matter to the governing body and request that the governing body make the necessary changes. Failing this, we would be required to modify this report relating to the fact that the format of the digital consolidated financial statements included in the Group's annual financial report are, in all material respects, drawn up in accordance with the ESEF requirements under the Delegated Regulation.
This report complies with the content of our additional report intended for the audit committee referred to in Article 11 of Regulation (EU) No 537/2014.
Antwerp, 29 APRIL 2022
RSM RÉVISEURS D'ENTREPRISES - BEDRIJFSREVISOREN BV-SRL STATUTORY AUDITOR REPRESENTED BY GERT VAN LEEMPUT PARTNER
| 1st interim statement | 25 May 2022 |
|---|---|
| Annual general meeting | 7 June 2022 |
| Half-year results | 30 September 2022 |
| 2nd interim statement | 30 November 2022 |
Drève Richelle 161 P, bte 4, Waterloo Office Park, B- 1410 WATERLOO - www.floridienne.be
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.